Continuous glucose monitoring reveals trade-off between glucose control and daily well-being
New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, shows that among people living with type 1 or type 2 diabetes, data from continuous glucose monitoring (CGM) devices paired with daily quality-of-life ratings found that days with more widely fluctuating glucose readings (while still within safe limits)…
New research presented at the European Association for the Study of Diabetes' Annual Meeting in Milan reveals a potential trade-off between glucose control and daily well-being for individuals with type 1 or type 2 diabetes. Professor Dominic Ehrmann and colleagues from the Research Institute Diabetes Academy Mergentheim studied 400 individuals with diabetes, using continuous glucose monitoring (CGM) data paired with daily quality-of-life assessments.
The study found that days with more stable glucose readings within safe limits were followed by days with better quality of life than days with stricter control. Higher glucose variability and longer time in the normal blood sugar range on the previous day were significantly associated with improved next-day quality of life. While higher sleep quality and energy levels on the previous day also predicted better next-day well-being, time above or below the safe glucose range on the prior day did not show a statistically significant association.
The authors suggest that stricter glucose control may burden individuals, potentially limiting their ability to participate in activities and contributing to lower quality of life.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
